Atrial Fibrillation Surgery Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-1102 | Report Format : | Status : Upcoming |

Abstract

Global Atrial Fibrillation Surgery Market: Overview

The heart contracts and relaxes in a regular interval of time. There are certain cells in the heart that impulse electric signals and cause the heart to contract and pump blood. These electrical signals can see and record with the help of electrocardiogram (ECG). In atrial fibrillation (AFib), two small upper chambers known as atria of the heart do not beat at the same time as the way they should. However, they beat irregularly and too fast and trembling like a bowl of gelatin. It is important for atria to beat in order to pump properly in order to supply oxygen and food. Atrial fibrillation can be treated by medications and slowing the heart rate to the rhythm control stage. This may cause strokes, heart failure, blood cloth, and others heart problems. If kept untreated, the risk associated with atrial fibrillation results in death. Hypertension and valvular heart disease are commonly seen risk factors of atrial fibrillation disease.

Global Atrial Fibrillation Surgery Market: Growth Factors

Expanding pharmacies & drug stores and public and private hospitals are expected to propel the global atrial fibrillation surgery market growth. Rising prevalence of hypertension, obesity and other heart problems among the aging population is also anticipated to fuel the global market growth. Reduced mortality rate and positive outcomes of the atrial fibrillation device are anticipated to enhance the global market in the coming years.

Global Atrial Fibrillation Surgery Market: Segmentation

The global atrial fibrillation surgery market is categorized based on the end user as ambulatory surgical centers, hospitals, and cardiac catheterization laboratories. On the basis of surgical type, the global market is classified as maze surgery and catheter ablation. Of these, catheter ablation is the leading surgical type segment in the global market. Escalating demand for non-pharmacological treatments, rising patient awareness, and improved healthcare infrastructure are some factors responsible for the growth of catheter ablation segment. Based on the non-surgical type, the global atrial fibrillation surgery market is fragmented as the left atrial appendage, electric cardioversion, pharmacological drugs, access devices, closure devices, diagnostic devices, cardiac monitors, and recording systems. Of these, pharmacological drug non-surgical type segment shows a considerable growth in the near future. However, increasing use of anti-coagulant therapy and chip prices of pharmacological drugs are driving the global atrial fibrillation surgery market growth.

Global Atrial Fibrillation Surgery Market: Regional Analysis

The geographic region in the global atrial fibrillation surgery market includes North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America contributed the largest market share in the global market. Europe and Asia Pacific are following the same trend owing to the high prevalence of atrial fibrillation and increasing awareness among the population. Asia Pacific is growing at a faster rate as the geriatric population in this region is increasing and rising per capita income positively enhances the global atrial fibrillation surgery market growth. Developing economies such as Japan and China are grabbing largest market chunks as they are their expanding healthcare infrastructure. Various financial institutes are assisting with better reimbursement policies further boosting the global market growth in Europe. Moreover, improved healthcare expenditure in the Middle East and Africa is influencing the global market growth.

Global Atrial Fibrillation Surgery Market: Competitive Players

Major players dominating the global atrial fibrillation surgery market are Siemens Healthcare, Boston Scientific Corporation, St. Jude Medical, Inc., AtriCure, Inc., and Abbott. Other players include Medtronic plc, Biosense Webster, Inc., and Koninklijke Philips N.V.

Global Atrial Fibrillation Surgery Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Vitreous Tamponades Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2539 | Report Format:

Global Vitreous Tamponades Market: Overview Vitreous tamponades are the postoperative devices utilized in the retinal detachment vitrectomy processes. Retinal detachment is extremely grave medical condition and if not taken care of on time, can result in eternal vision loss. Vitrectomy is a surg...Read More

Operating Room Equipment Market by Product (Anesthesia Devices, Endoscopes, Operating room Lights, Operating Tables, Electrosurgical Devices, Surgical Imaging Devices and Patient Monitors), For Hospitals, Outpatient Facilities and Ambulatory Surgical Centers: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016-2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2515 | Report Format:

The operating room equipment market report includes comprehensive and profound analysis on the global and regional level. The report gives historic data of 2014 along with a forecast from 2017 to 2022 based on revenue (USD Billion). The study comprises drivers, restraints, and opportunities for th...Read More

Heart Valve Devices Market by Procedure (Heart Valve Replacement Devices (Mechanical Valve, Bioprosthetic Valve, TAVR) & Position (Mitral Valve, Aortic Valve, Other), Heart valve Repair Devices (Surgical Valve, Balloon Valvuloplasty Devices, TMVR)), by End User (Hospitals and Ambulatory Surgical Centers), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016- 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2511 | Report Format:

The report covers forecast and analysis for the Heart Valve Devices Market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the heart valve devices market ...Read More

Choose License Type:
Latest Published Reports

View All Published Reports